Orthofix Medical Inc. (OFIX) Cash Flow Statement
Orthofix Medical Inc. (OFIX) generated $16.3M of operating cash flow over the twelve months to 2026-06-30, spent $44.1M on capital expenditure and had free cash flow of -$27.8M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OFIXOrthofix Medical Inc.Follow OFIX — free
—
Price chart with a free account
- Market cap
- 399.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 64.7 | 10.2 | 67.0 | 51.0 | 43.6 | 59.1 | 39.0 | 49.9 | 32.0 | 74.3 | 18.5 | -11.5 | -45.8 | 25.8 | 33.3 | 16.3 | |
| Capital expenditure | 25.0 | 28.0 | 24.8 | 18.1 | 27.2 | 16.4 | 14.7 | 13.6 | 19.0 | 15.5 | 17.8 | 21.4 | 62.1 | 34.9 | 34.6 | -44.1 | |
| Free cash flow | 39.8 | -17.8 | 42.3 | 32.9 | 16.4 | 42.6 | 24.3 | 36.3 | 13.0 | 58.8 | 0.7 | -32.9 | -107.8 | -9.1 | -1.3 | -27.8 | |
| Share repurchases | — | — | 39.5 | — | 11.6 | 63.4 | — | — | — | — | — | — | — | — | — | — | |
| Stock-based compensation | 6.6 | 6.3 | 6.3 | 5.7 | 7.2 | 16.0 | 12.6 | 18.9 | 21.5 | 16.2 | 15.4 | 18.4 | 35.7 | 32.5 | 28.7 | — |
USD millions · SEC XBRL
Orthofix Medical Inc. — questions
- What is Orthofix Medical Inc.'s operating cash flow?
- $16.3M over the twelve months to 2026-06-30.
- How much does Orthofix Medical Inc. spend on capital expenditure?
- $44.1M over the twelve months to 2026-06-30.
- What is Orthofix Medical Inc.'s free cash flow?
- -$27.8M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Orthofix Medical Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.